Group 1 - Beijing Ruifen Biotechnology Co., Ltd. has completed a C-round financing of over 100 million yuan [1] - The financing was led by Xingxiang Capital, with Ruipeng Xiangyu Fund participating [1] - Funds raised will be used to promote commercialization and new capacity construction, accelerating R&D innovation and market expansion in both human and animal health platforms [1] Group 2 - Ruifen Biotechnology was founded in 2007 and aims to be a trusted partner in the global health industry, focusing on sustainable development of natural raw materials [1] - The company is committed to the "carbon neutrality" strategy and seeks to redefine natural products, providing integrated solutions that balance taste, functionality, nutrition, appearance, and cost for the food, beverage, and nutritional supplement industries [1]
瑞芬生物完成C轮融资,易凯资本担任独家财务顾问
Cai Jing Wang·2025-12-29 07:31